| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.004 | 1 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.0063 | 1 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.00088 | 1 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.0046 | 1 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00067 | 1 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.00046 | 1 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.00098 | 1 |